98%
921
2 minutes
20
The putative cache (Ca channel and chemotaxis receptor) domain containing 1 (CACHD1) protein has predicted structural similarities to members of the α2δ voltage-gated Ca channel auxiliary subunit family. CACHD1 mRNA and protein were highly expressed in the male mammalian CNS, in particular in the thalamus, hippocampus, and cerebellum, with a broadly similar tissue distribution to Ca3 subunits, in particular Ca3.1. In expression studies, CACHD1 increased cell-surface localization of Ca3.1, and these proteins were in close proximity at the cell surface, consistent with the formation of CACHD1-Ca3.1 complexes. In functional electrophysiological studies, coexpression of human CACHD1 with Ca3.1, Ca3.2, and Ca3.3 caused a significant increase in peak current density and corresponding increases in maximal conductance. By contrast, α2δ-1 had no effect on peak current density or maximal conductance in Ca3.1, Ca3.2, or Ca3.3. A comparison of CACHD1-mediated increases in Ca3.1 current density and gating currents revealed an increase in channel open probability. In hippocampal neurons from male and female embryonic day 19 rats, CACHD1 overexpression increased Ca3-mediated action potential firing frequency and neuronal excitability. These data suggest that CACHD1 is structurally an α2δ-like protein that functionally modulates Ca3 voltage-gated calcium channel activity. This is the first study to characterize the Ca channel and chemotaxis receptor domain containing 1 (CACHD1) protein. CACHD1 is widely expressed in the CNS, in particular in the thalamus, hippocampus, and cerebellum. CACHD1 distribution is similar to that of low voltage-activated (Ca3, T-type) calcium channels, in particular to Ca3.1, a protein that regulates neuronal excitability and is a potential therapeutic target in conditions such as epilepsy and pain. CACHD1 is structurally an α2δ-like protein that functionally increases Ca3 calcium current. CACHD1 increases the presence of Ca3.1 at the cell surface, forms complexes with Ca3.1 at the cell surface, and causes an increase in channel open probability. In hippocampal neurons, CACHD1 causes increases in neuronal firing. Thus, CACHD1 represents a novel protein that modulates Ca3 activity.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199404 | PMC |
http://dx.doi.org/10.1523/JNEUROSCI.3572-15.2018 | DOI Listing |
Toxicol Appl Pharmacol
October 2025
College of Pharmacy, Taizhou University, Taizhou, Jiangsu 225300, PR China. Electronic address:
Breast cancer is a major global health challenge with high incidence and mortality. CDK4/6 inhibitors like Ribociclib have shown clinical benefits, but drug resistance remains a limitation. We designed and synthesized a novel Ribociclib derivative, Rib-CA, and evaluated its antitumor effects using in vitro assays (MTT, colony formation, EdU incorporation, cell adhesion, Transwell invasion, and wound healing) and in vivo models (CAM assay, xenografts).
View Article and Find Full Text PDFMol Cell Proteomics
July 2025
German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Neuroproteomics, School of Medicine and Health, TUM University Hospital, Technical University of Munich, Munich, Germany; Munich Cluster for System Neurology (SyNergy), Munich, Germany. Electronic address: Stefan.Lichtenthaler@dzn
The β-secretase β-site APP cleaving enzyme 1 (BACE1) is a major drug target for Alzheimer's disease (AD). Clinically tested BACE1 inhibitors induced unexpected cognitive side effects that may stem from their cross-inhibition of the homologous protease BACE2. Yet, little is known about BACE2 functions and substrates in vivo, and no biomarker is available to monitor the extent of BACE2 inhibition in vivo, particularly in cerebrospinal fluid (CSF).
View Article and Find Full Text PDFJ Gerontol A Biol Sci Med Sci
May 2025
The Key Laboratory of Geriatrics, Beijing Institute of Geriatrics, Beijing Hospital, National Center of Gerontology, National Health Commission, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
The aging of the population is a global concern. In the post-coronavirus disease 2019 (COVID-19) pandemic era, there are no effective methods to identify aging acceleration due to infection. In this study, we conducted whole-transcriptome sequencing on peripheral blood samples from 35 healthy individuals (22-88 years old).
View Article and Find Full Text PDFTrends Biochem Sci
December 2024
Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. Electronic address:
Wnt morphogens induce signaling via binding their extracellular receptors. Here, we discuss several recent structural studies showing how Wnts engage their receptors frizzled (FZD) and low-density lipoprotein receptor-related protein 5/6 (LRP5/6), how Cachd1 has been shown as an alternative initiator of Wnt signaling, and how lipidated Wnt may be produced and secreted from the cell.
View Article and Find Full Text PDFScience
May 2024
Cell and Developmental Biology, Division of Biosciences, University College London, London WC1E 6BT, UK.
Neurons on the left and right sides of the nervous system often show asymmetric properties, but how such differences arise is poorly understood. Genetic screening in zebrafish revealed that loss of function of the transmembrane protein Cachd1 resulted in right-sided habenula neurons adopting left-sided identity. Cachd1 is expressed in neuronal progenitors, functions downstream of asymmetric environmental signals, and influences timing of the normally asymmetric patterns of neurogenesis.
View Article and Find Full Text PDF